raw data derived by quantification of complement components and activation products in plasma samples of myasthenia gravis (MG) patients positive for anti-achr and anti-musk autoantibodies and healthy
Chronic CSC patients were divided into 2 groups: patients who had used steroids within 1 year before diagnosis versus patients who had not used steroids within 1 year before diagnosis.
raw data derived by quantification of complement components and activation products in plasma samples of myasthenia gravis (MG) patients positive for anti-achr and anti-musk autoantibodies and
